Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07695454 · ClinicalTrials.gov registry record
Imaging in Semaglutide Study
A clinical trial, sponsored by The Cleveland Clinic.
- Not yet
- Registry status
- 10
- Enrollment target
NCT07695454 is a clinical trial that has not yet begun recruiting, run by The Cleveland Clinic. The registered enrollment target is 10 participants.
The verdict
NCT07695454 has not yet begun recruiting, sponsored by The Cleveland Clinic.
- NOT YET RECRUITING
- Registry status
- 10 participants
- Enrollment target
Study Summary
In this preliminary observation study, the investigators will assess muscle function in terms of muscle strength and leverage imaging (MRI) and spectroscopy (31P-MRS) based techniques to assess longitudinal changes in muscle volume, quality and metabolic function in patients with T2D and obesity prescribed to semaglutide therapy. The patients will be evaluated at three time points: 1) baseline, 2) 3-month and 3) 6-month after the therapy. These longitudinal changes will then be compared and correlated with changes in physical measurements such as BMI and patient reported outcome measures (PROMs). The primary aim of our study is to investigate the longitudinal effects of semaglutide therapy on patients with T2D and obesity, on skeletal muscle strength, muscle volume, quality and metabolic function.
Interventions
- RADIATION 31P-MRS and MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2026-07-15 |
| Est. Completion | 2027-06-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07695454
The ClinicalTrials.gov registry entry for NCT07695454 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 31P-MRS and MRI is the first listed.
NCT07695454 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07695454 about?
NCT07695454 is a clinical study titled "Imaging in Semaglutide Study". In this preliminary observation study, the investigators will assess muscle function in terms of muscle strength and leverage imaging (MRI) and spectroscopy (31P-MRS) based techniques to assess longitudinal changes in muscle volume, quality and metabolic function in patients with T2D and obesity pre...
What is the current status of trial NCT07695454?
This trial is currently not yet recruiting. The enrollment target is 10 participants. The study started on 2026-07-15. Estimated completion is 2027-06-01.
What interventions are being tested in trial NCT07695454?
The interventions under investigation include: 31P-MRS and MRI (RADIATION).
Who is sponsoring clinical trial NCT07695454?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.